• LAST PRICE
    0.0030
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0030 / 0.0030
  • Day Range
    Low 0.0030
    High 0.0030
  • 52 Week Range
    Low 0.0026
    High 0.0699
  • Volume
    529
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 0.003
TimeVolumeTHCT
12:23 ET1000.003
03:25 ET4100.003
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTHCT
THC Therapeutics Inc
102.4K
0.0x
---
United StatesPHOT
GrowLife Inc
23.6K
0.0x
---
United StatesUSDF
US-Dadi Fertilizer Industry International Inc
9.8K
-0.5x
---
United StatesHIMR
Hollund Industrial Marine Inc
5.3K
0.0x
---
United StatesLGAH
LGA Holdings Inc
370.1K
0.0x
---
United StatesTAKD
Transakt Ltd
1.5M
-7.1x
---
As of 2023-09-27

Company Information

THC Therapeutics, Inc. (THCT) is a cannabis company engaged in developing a premiere line of cannabinoid and terpene formulations designed to allow for tailored effects. The Company is also focused on developing a sanitizing herb dryer, the dHydronator, which is specifically designed for the drying and sanitizing, including reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The Company’s dHydronator product can reduce moisture content of cannabis to 10-15% in only 10-14 hours. The dHydronator can also significantly reduce the bacterial count of the cannabis during the drying process, and it does not eliminate all bacteria from the cannabis or other plant materials.

Contact Information

Headquarters
11700 W CHARLESTON BLVD #73LAS VEGAS, NV, United States 89135
Phone
702-602-8422
Fax
---

Executives

President, Chief Executive Officer, Company Secretary, Director
Brandon Romanek
Head of Design
Victor Nacif
Medical Director
John Pierce
Lead Researcher
Natalia Tafur
Director
Parker Mitchell

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$102.4K
Revenue (TTM)
$0.00
Shares Outstanding
34.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.46
EPS
$-0.09
Book Value
$-0.09
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.